Radiation Dose, Chemotherapy and Risk of Lung Cancer After Breast Cancer Treatment

By Rubino C.  

Breast Cancer Research and Treatment, Vol. 75, Iss. 1, 2002-09 ,pp. : 15-24

Springer Publishing Company

Access to resources Recommend Favorite

Soft tissue sarcoma after treatment for breast cancer-A Swedish population-based study

By Karlsson P.   Holmberg E.   Samuelsson A.   Johansson K.-A.   Wallgren A.  

European Journal of Cancer, Vol. 34, Iss. 13, 1998-12 ,pp. : 2068-2075

Elsevier

Access to resources Recommend Favorite

Risk factors for hematological toxicity of chemotherapy for bone and soft tissue sarcoma

By Ouyang Zhengxiao   Peng Dan   Dhakal Dibya Purush  

Oncology Letters, Vol. 5, Iss. 5, 2013-05 ,pp. : 1736-1740

Spandidos Publications

Access to resources Recommend Favorite

Epirubicin is not superior to doxorubicin in the treatment of advanced soft tissue sarcomas. The experience of the EORTC soft tissue and bone sarcoma group

By Nielsen Ole S.   Mouridsen Henning   Daugaard Soren   Verweij Jaap   Dombernowsky Per   Van Glabbeke Martine   Kirkpatrick Anne  

Sarcoma, Vol. 4, Iss. 1-2, 2000-03 ,pp. : 31-35

Informa Healthcare

Access to resources Recommend Favorite

Effect of high-dose ifosfamide in advanced soft tissue sarcomas. A multicentre phase II study of the EORTC Soft Tissue and Bone Sarcoma Group - is it feasible?

By Nielsen O.S.   Judson I.   van Hoesel Q.   le Cesne A.   Keizer H.J.   Blay J.Y.   van Oosterom A.   Radford J.A.   Svancarova L.   Krzemienlecki K.   Hermans C.   van Glabbeke M.   Oosterhuis J.W.   Verweij J.  

European Journal of Cancer, Vol. 36, Iss. 1, 2000-01 ,pp. : 61-67

Elsevier

Access to resources Recommend Favorite